Challenges and Variables Affecting the Success of Sentinel Lymph Node Biospy in Malignant Melanoma a 4-Year Analysis of Clinical Results

1. Wikipedia, the Free Encyclopedia [Internet], Melanoma, [cited 2013Jan 18]. Available from: http://en.wikipedia.org/wiki/MelanomaSearch in Google Scholar

2. Dimitrova N, Vukov M, Valerianova Z, editors. Cancer incidence in Bulgaria 2009. Vol XX. Bulgarian National Cancer Registry: Publisher “AVIS-24” Ltd.; 2011.Search in Google Scholar

3. North JH Jr, Spellman JE. Role of sentinel node biopsy in the management of malignant melanoma. Oncology (Huntington). 1996; 10(8): 1237-42.Search in Google Scholar

4. Lingam MK, Mackie RM, McKay AJ. Intraoperative identification of sentinel node in patients with malignant melanoma. Br J Cancer. 1997;75( 10): 1505-8.10.1038/bjc.1997.257Search in Google Scholar

5. James WD, Berger TG, Elston DM. Melanocytic nevi and neoplasms. In: Andrews' Diseases of the Skin: Clinical Dermatology. 11th ed. Saunders Elsevier; 2011.p.675-93.10.1016/B978-1-4377-0314-6.00030-9Search in Google Scholar

6. Sanchez RL, Raimer S. Pigmentary disturbances and melanocytic tumors. In: Sanchez RL, Raimer S, editors. Vademecum Dermatopathology. Georgetown, Texas: Landes Bioscience: 2001. p. 270-85.Search in Google Scholar

7. Marghoob AA, Koenig K, Bittencourt FV, Kopf AW, Bart RS. Breslow thickness and Clark level in melanoma: support for including level in pathology reports and American Joint Committee on Cancer Staging. Cancer. 2000;88(3):589-95.10.1002/(SICI)1097-0142(20000201)88:3<589::AID-CNCR15>3.0.CO;2-ISearch in Google Scholar

8. Testoril A, Rutkowski P, Marsden J, Bastholt L, Chiarion-Sileni V, Hauschild A, et al. Surgery and radiotherapy in the treatment of cutaneous melanoma. Ann Oncol. 2009;20(Suppl 6):vi22-vi29.10.1093/annonc/mdp257Search in Google Scholar

9. Jakub JW, Pendas S, Reintgen DS. Current Status of Sentinel Lymph Node Mapping and Biopsy: Facts and Controversies. Oncologist. 2003;8(1): 59-68.10.1634/theoncologist.8-1-59Search in Google Scholar

10. McKenna DB, Marioni JC, Lee RJ, Prescott RJ, Doherty VR. A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma. Br J Dermatol. 2004; 151 (3):636-44.10.1111/j.1365-2133.2004.06065.xSearch in Google Scholar

11. Morton DL, Thompson JF, Essner R, Elashoff R, Stem S, Nieweg O, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma. Ann Surg. 1999;230(4):453-63.10.1097/00000658-199910000-00001Search in Google Scholar

12. Bostick P, Esner R, Glass E. Comparison of Blue Dye and Probe-Assisted Intraoperative Lymphatic Mapping in Melanoma to Identity Sentinel Nodes in 100 Lymphatic Basins. Arch Surg. 1999; 134(l):43-9.10.1001/archsurg.134.1.43Search in Google Scholar

13. O’Brien CJ, Uren RF, Thompson JF, Howman-Giles RB, Petersen-Schaefer K, Shaw HM, et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg. 1995; 170(5):461 -6.10.1016/S0002-9610(99)80330-4Search in Google Scholar

14. Uren RF, Howman-Giles R, Thompson JF. Patterns of Lymphatic Drainage from the Skin in Patients with Melanoma. J Nucl Med. 2003;44(4):570-82. Search in Google Scholar